Drug Trial Radar · NCT04598893
Recent-Onset Type 1 Diabetes Extension Study Evaluating the Long-Term Safety of Teplizumab (PROTECT Extension)
Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
188
Actual
Start
Oct 26, 2020
Primary completion
Nov 12, 2026
Study completion Nov 12, 2026
Sponsor
- Lead sponsor
- Provention Bio, a Sanofi CompanyIndustry
- Sponsor type
- Industry
- First posted
- Oct 22, 2020
Design
- Study type
- Observational
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 9 years, up to 19 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this non-interventional extension study is to continue to collect long-term safety and other clinical data for an additional 42 months in participants who completed the PROTECT study.
Conditions
- Diabetes Mellitus, Type 1
Interventions
TeplizumabBiological
Received teplizumab in PROTECT Study
PlaceboOther
Received placebo in PROTECT study
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of adverse events (AEs), serious adverse events (SAEs) and adverse events of special interest (AESIs), including infections and malignanciesTime frame: During 42 months of follow-up
Locations
47 sites in 8 countries. Site status is shown where the registry gives one.
Rady Children's Hospital 3020 Children's Way (Site 840004)
San Diego, California
UCSF Medical Center Gateway Medical Building, 1825 Fourth Street (Site 840001)
San Francisco, California
Diablo Clinical Research2255 Ygnacio Valley Road, Ste. M (Site 840002)
Walnut Creek, California
Barbara Davis Center for Diabetes - Pediatrics 1775 Aurora Court (Site 840005)
Aurora, Colorado
Nemours Children's Health, 807 Children's Way
Jacksonville, Florida
Johns Hopkins All Children's Hospital, 501 6th Avenue South (Site 840048)
St. Petersburg, Florida
Atlanta Diabetes Associates 1800 Howell Mill Road. Suite 450 (Site 840009)
Atlanta, Georgia
Centricity Research (Site 840006)
Columbus, Georgia
St. Luke's Children's Endocrinology, 305 E Jefferson St. (Site 840052)
Boise, Idaho
Rocky Mountain Clinical Research, LLC 3910 Washington Parkway, Suite E (Site 840007)
Idaho Falls, Idaho
Indiana University Hospital, Indiana Clinical Research Center, 550 North University Boulevard (Site 840014)
Indianapolis, Indiana
University of Iowa Hospitals and Clinics 200 Hawkins Drive (Site 840023)
Iowa City, Iowa
Capital Medical Research Associates (Site 840029)
Camp Springs, Maryland
Baystate Medical Center, 759 Chestnut Street
Springfield, Massachusetts
Children's Mercy Hospitals and Clinics, 2401 Gillham Road (Site 840026)
Kansas City, Missouri
Washington University School of Medicine, Pediatric Clinical Research Unit, Suite 11W19 (Site 840018)
St Louis, Missouri
UBMD Pediatrics 1001 Main Street, 4th Floor (Site 840010)
Buffalo, New York
UNC Hospitals, The University of North Carolina at Chapel Hill, Children's Specialty Clinic, 101 Manning Drive (Site 840038)
Chapel Hill, North Carolina
Endocrinology Service Northwest, LLC 929 SW Simpson Ave. Suite 220 (Site 840034)
Bend, Oregon
Children's Hospital of Philadelphia, Division of Endocrinology 3500 Civic Center Blvd., Buerger Center 12th Floor (Site 840021)
Philadelphia, Pennsylvania
AM Diabetes & Endocrinology Center, 3025 Kate Bond Rd. (Site 840008)
Bartlett, Tennessee
Vanderbilt University Medical Center 1500 21st Avenue, Suite 1514, Village At Vanderbilt (Site 840024)
Nashville, Tennessee
UT Southwestern Children's Medical Center of Dallas 1935 Medical District Drive (Site 840033)
Dallas, Texas
Virginia Mason Medical Center, Benaroya Research Institute 1201 9th Ave, MS: D4-CRP (Site 840016)
Seattle, Washington
MultiCare Health System, Gateway Medical Building (Site 840003)
Tacoma, Washington
UCL Namur University Hospital Place Louise Godin 15 (Site 056205)
Namur, Belgium
University Hospital Brussels (Site 056202)
Jette, Brussels Capital, Belgium
Alberta Diabetes Institute, 2-004 Li Ka Shing Centre for Health Research Innovation 8602 (Site 124103)
Edmundston, Alberta, Canada
BCDiabetes - Medical Research Center, 210 West Broadway Suite 400 (Site 124102)
Vancouver, British Columbia, Canada
University Hospital Motol V Uvalu 84, Praha 5 - Motol (Site 203301)
Prague, Czechia
Woman Mother Child Hospital HCL
Bron, France
Dijon University Hospital Center-Francois Mitterand Hospital, Children's Hospital
Dijon, France
CHU La Timone - La Timone Children's Hospital
Marseille, France
Lenval Hospital, 57 Avenue de la Californie (Site 250508)
Nice, France
Hospital Center Regional D'Orleans Hospital La Source, Pediatric Department, 14 Hospital Ave Post box 86709 (Site 250513)
Orléans, France
Necker Children's Hospital, 149 Rue de Sevres (Site 250502)
Paris, France
Pau Hospital Center
Pau, France
Hospital Augsburg, Stenglinstrasse 2 (Site 276606)
Augsburg, Germany
University Hospital Carl Gustav Carus Fetscherstrasse 74 (Site 276601)
Dresden, Germany
Pediatric Hospital on the Bult Janusz-Korczak-Allee 12 (Site 276604)
Hanover, Germany
Showing 40 of 47 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.